Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Increased by Diligent Investors LLC

Diligent Investors LLC lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 87.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,520 shares of the pharmacy operator's stock after acquiring an additional 68,264 shares during the period. Diligent Investors LLC's holdings in Walgreens Boots Alliance were worth $1,367,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. Invesco Ltd. raised its holdings in Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after acquiring an additional 2,631,332 shares during the period. Geode Capital Management LLC lifted its holdings in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after purchasing an additional 1,020,587 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after buying an additional 2,185,950 shares during the last quarter. Finally, Northern Trust Corp grew its stake in Walgreens Boots Alliance by 18.8% during the fourth quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock valued at $83,007,000 after acquiring an additional 1,407,973 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock traded up $0.08 during trading hours on Friday, reaching $11.24. 8,465,216 shares of the company's stock were exchanged, compared to its average volume of 21,050,405. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company's 50 day moving average is $11.00 and its two-hundred day moving average is $10.28. The company has a market cap of $9.72 billion, a P/E ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.20 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Activity

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the company's stock in a transaction dated Sunday, April 27th. The shares were acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares in the company, valued at $1,603,288,079.79. The trade was a 0.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 17.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on WBA. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Bank of America boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Finally, Royal Bank of Canada boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.